Jody S. Garey
Jody S. Garey publishes mostly in Economics and Econometrics, Oncology and Public Health, Environmental and Occupational Health, on topics such as Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life and Colorectal Cancer Treatments and Studies.
- World rank
- #2,030,763 of 7,710,434 ranked researchers
- Rank in United States
- #615,441 of 1,627,098
- Works
- 63
- Citations
- 882
- Citations per work
- 14.0
What does Jody S. Garey research?
Jody S. Garey's work is mostly in Medicine (40%), Economics, Econometrics and Finance (34%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2539.5%
- Medicine2539.5%
- Social Sciences2133.5%
- Everything else1421.6%
- Life Sciences35.4%
- 1Economics and Econometrics34% of their works
- 2Oncology25% of their works
- 3Public Health, Environmental and Occupational Health8% of their works
- 4Immunology5% of their works
- 5Pulmonary and Respiratory Medicine4% of their works
- 6Radiology, Nuclear Medicine and Imaging2% of their works
Research topics
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Colorectal Cancer Treatments and Studies
- Biosimilars and Bioanalytical Methods
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology
- Clinical practice guidelines implementation
- Palliative Care and End-of-Life Issues
Which keywords describe Jody S. Garey's research?
The keywords of their largest research topics: Cost of Care, Financial Toxicity, Quality of Life, Chemotherapy, Cost-effectiveness Analysis, Health Utility Measures, Cetuximab and KRAS Mutations.
- Palliative Care
- Guideline Development
- Taxanes
- Immunogenicity
- Biosimilars
- KRAS Mutations
- Health Utility Measures
- Chemotherapy
- Financial Toxicity
- Cost of Care
- Quality of Life
- Cost-effectiveness Analysis
- Cetuximab
- Antimicrobial Agents
- Febrile Neutropenia
- Chemotherapy-Induced Peripheral Neuropathy
- Clinical Guidelines
- End-of-Life
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Cost of Care331 topic
- Financial Toxicity331 topic
- Quality of Life262 topics
- Chemotherapy212 topics
- Cost-effectiveness Analysis181 topic
- Health Utility Measures181 topic
- Cetuximab121 topic
- KRAS Mutations121 topic
- Antimicrobial Agents91 topic
- Biosimilars91 topic
- Febrile Neutropenia91 topic
- Immunogenicity91 topic
- Chemotherapy-Induced Peripheral Neuropathy81 topic
- Taxanes81 topic
- Clinical Guidelines61 topic
- Guideline Development61 topic
- End-of-Life51 topic
- Palliative Care51 topic
Where does Jody S. Garey work?
Jody S. Garey's main affiliation in the publication record is The US Oncology Network, United States.
How many publications and citations does Jody S. Garey have?
OpenAlex counts 63 works and 882 citations for Jody S. Garey, an h-index of 9, ranking #2,030,763 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jody S. Garey. Posts are plain text and can be reported.